Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
GlaxoSmithKline ( (GB:GSK) ) has issued an update.
GlaxoSmithKline (GSK) announced the repurchase of 170,000 ordinary shares as part of its ongoing buyback program, executed through BNP Paribas SA. This transaction, conducted on November 17, 2025, involved shares purchased at prices ranging from 1,781.00p to 1,800.50p, with an average price of 1,789.39p. The repurchased shares will be held as treasury shares, contributing to a total of 256,634,844 shares in treasury. This move is part of GSK’s strategy to manage its capital structure and return value to shareholders, reflecting confidence in its financial health and future prospects.
The most recent analyst rating on (GB:GSK) stock is a Sell with a £15.00 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GB:GSK Stock
According to Spark, TipRanks’ AI Analyst, GB:GSK is a Outperform.
GlaxoSmithKline’s strong financial performance and positive earnings call sentiment are the most significant factors driving the stock score. The company’s robust growth in specialty medicines and successful R&D efforts contribute positively. Technical analysis supports a bullish outlook, while valuation remains reasonable with an attractive dividend yield. Challenges in the U.S. vaccines market and clinical trial delays are noted but do not significantly detract from the overall positive outlook.
To see Spark’s full report on GB:GSK stock, click here.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a leading global healthcare company engaged in the development and production of pharmaceuticals, vaccines, and consumer healthcare products. The company focuses on innovative medicines and vaccines, with a strong presence in both developed and emerging markets.
Average Trading Volume: 8,462,487
Technical Sentiment Signal: Buy
Current Market Cap: £71.68B
See more insights into GSK stock on TipRanks’ Stock Analysis page.